Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Parkinson´s Disease”

Showing 20 of 0 results

Not applicableLooking for participantsNCT07337226
What this trial is testing

Association of VAgus Nerve Stimulation and Treadmill Training for GAit Rehabilitation in DE Novo Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease (PD)
Fondazione Policlinico Universitario Campus Bio-Medico 60
Early research (Phase 1)Looking for participantsNCT07195825
What this trial is testing

A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease

Who this might be right for
PD
Shanghai Xinzhi BioMed Co., Ltd. 18
Not applicableLooking for participantsNCT06891781
What this trial is testing

Investigating Adaptive Deep Brain Stimulation in Parkinson's Disease Management

Who this might be right for
Parkinson Disease, Idiopathic
Newronika 104
Early research (Phase 1)Study completedNCT00507715
What this trial is testing

Study of the Modification of the Pharmacokinetic Profile of Levodopa by the Fiber Plantago Ovata Husk

Who this might be right for
Parkinson's Disease, Idiopathic
Rottapharm Spain 18
Testing effectiveness (Phase 2)Study completedNCT00111982
What this trial is testing

Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin

Who this might be right for
Parkinson's Disease
Amgen 34
Not applicableStudy completedNCT02227355
What this trial is testing

Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
UCB Biopharma S.P.R.L. 195
Not applicableUnknownNCT02494908
What this trial is testing

Evidence of Neuroplasticity After Performing a Cognitive Task in Idiopathic Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Dr. Sharon Hassin 80
Large-scale testing (Phase 3)Study completedNCT01286935
What this trial is testing

18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 544
Early research (Phase 1)Study completedNCT05924243
What this trial is testing

Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.

Who this might be right for
Parkinson Disease
Hoffmann-La Roche 60
Post-approval studies (Phase 4)Ended earlyNCT00642356
What this trial is testing

Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off

Who this might be right for
Parkinson's Disease
Novartis 14
Post-approval studies (Phase 4)Study completedNCT01300819
What this trial is testing

Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms

Who this might be right for
Idiopathic Parkinson's Disease
UCB Pharma 349
Early research (Phase 1)Study completedNCT00252850
What this trial is testing

Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
Sangamo Therapeutics 12
Early research (Phase 1)Looking for participantsNCT07840027
What this trial is testing

Assessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)Idiopathic Parkinson's Disease
Tridem Bioscience FlexCo 36
Post-approval studies (Phase 4)Study completedNCT00437125
What this trial is testing

Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease

Who this might be right for
Major Depressive DisorderIdiopathic Parkinson Disease
Eli Lilly and Company 151
Large-scale testing (Phase 3)Study completedNCT02240030
What this trial is testing

Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 351
Not applicableWithdrawnNCT04101513
What this trial is testing

The Natural History of Parkinson's Disease-associated Spinal Disorders

Who this might be right for
Parkinson DiseaseIdiopathic Parkinson Disease
Ohio State University
Not applicableStudy completedNCT02248220
What this trial is testing

Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 657
Large-scale testing (Phase 3)UnknownNCT00909883
What this trial is testing

Foot Dystonia Treatment by Botulinum Toxin Injections in Parkinson Disease : Efficiency of Injections Made in Extrinsic Muscle (Flexor Digitorum Longus Muscle) Compared to Intrinsic Muscle (Flexor Digitorum Brevis or Quadratus Plantae Muscles)

Who this might be right for
Parkinson's DiseaseFoot Dystonia
University Hospital, Clermont-Ferrand 45
Not applicableStudy completedNCT02231294
What this trial is testing

The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 1,464
Not applicableStudy completedNCT01272687
What this trial is testing

Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation

Who this might be right for
Parkinson DiseaseIdiopathic Parkinson Disease
CENTOGENE GmbH Rostock 1,500
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation